Australian Pharmaceutical Industries Limited (ASX:API)

$1.75

right-arrow Created with Sketch. 0.015 (0.86%)
MCAP $854.7M
Last trade 16.10pm 03/12/2021 20mins delayed

Latest Announcements

03/12/2021APIAustralian Pharmaceutical Industries Limited
02/12/2021APIAustralian Pharmaceutical Industries Limited
02/12/2021 Price SensitivePSAPIAustralian Pharmaceutical Industries Limited
02/12/2021 Price SensitivePSAPIAustralian Pharmaceutical Industries Limited
18/11/2021APIAustralian Pharmaceutical Industries Limited
17/11/2021APIAustralian Pharmaceutical Industries Limited
12/11/2021APIAustralian Pharmaceutical Industries Limited
12/11/2021APIAustralian Pharmaceutical Industries Limited

Company Overview

Australian Pharmaceutical Industries Limited is an Australia-based pharmaceutical distributor, and health and beauty retailer company. The Company’s segments include Australia and New Zealand. The Australia segment is engaged in distribution of pharmaceutical, medical, health, beauty and lifestyle products and retail services to pharmacies, the purchase and sale of health, beauty and lifestyle products and services within the retail industry, including cosmetic products and non-invasive procedures. The New Zealand segment manufactures and owns rights for pharmaceutical medicines and consumer toiletries. The Company's brands include Priceline & Priceline Pharmacy, which is a health, beauty and wellbeing retailer; Soul Pattinson Chemist, which is a pharmacy brand; Pharmacist Advice, which offers professional service and advice; Club Premium, which is a club for independent pharmacies, and Pharmacy Best Buys, which offers a catalog program.

API in the news

A bidding war is underway between Sigma Healthcare (SIG) and Wesfarmers (WES)…
Australian Pharmaceutical Industries (API) is closing 14 of its non-pharmacy Priceline stores…
Australian Pharmaceutical Industries (API) has sold 137 million Sigma Healthcare shares, saying…

Search Previous Announcements